Transforming medical diagnosis with new scanning technology

A new technology which dramatically improves the sensitivity of Magnetic Resonance techniques including those used in hospital scanners and chemistry laboratories has been developed by British scientists. The technique could replace current clinical imaging technologies that depend on the use of radioactive substances or heavy metals, which themselves create health concerns.

Photo: Transforming medical diagnosis with new scanning technology

Ultimately, the technique, based on manipulating parahydrogen, the fuel of the space shuttle, is expected to allow doctors to learn far more about a patient’s condition from an MRI scan at lower cost while increasing the range of medical conditions that can be examined.

Researchers have taken parahydrogen and, through a reversible interaction with a specially designed molecular scaffold, transferred its magnetism to a range of molecules. The resulting molecules are much more easily detected than was previously possible. No-one has been able to use parahydrogen in this way before.

Professor Gary Green, from the Department of Psychology and Director of the York Neuroimaging Centre, said: "Our method has the potential to help doctors make faster and more accurate diagnoses in a wide range of medical conditions."

The new method will also have major implications for scientific research because it radically reduces the time taken to obtain results using Nuclear Magnetic Resonance technology, the most popular method for obtaining analytical and structural information in chemistry.

Professor Simon Duckett, from the University’s Department of Chemistry and Director of the Centre for Magnetic Resonance, said: "We have been able to increase sensitivity in NMR by over 1000 times so data that once took 90 days to record can now be obtained in just five seconds. Similarly, an MRI image can now be collected in a fraction of a second rather than over 100 hours.

"This development opens up the possibility of using NMR techniques to better understand the fundamental functions of biological systems."

Professor Ian Greer, Dean of the Hull York Medical School, said: "This technological advance has the potential to revolutionise the accessibility and application of high quality medical imaging to patients. It will bring significant benefits to diagnosis and treatment in virtually all areas of medicine and surgery, ranging from cancer diagnosis to orthopaedics and trauma. It illustrates the enormous success of combining high quality basic science with clinical application."

Bruker BioSpin has been one of the first collaborators in developing this technology for commercial use. Dr Tonio Gianotti, Director and International NMR Research and Development Co-ordinator for Bruker BioSpin, said: "This technology has the potential to revolutionise both NMR and MRI methods in a short space of time."

Dr Mark Mortimer, Director of the University’s Research and Enterprise Office, said: "The rapid development of this research from the chemistry bench through to measurement opens up many exciting possibilities to extend this work. The York research team are now seeking partners to help turn this groundbreaking research into commercial and medical applications."

Details of parahydrogen based hyperpolarisation methods and a video explaining the technique is available at lwww.york.ac.uk/res/sbd/parahydrogen/sabre.html

27.04.2009

More on the subject:
Read all latest stories

Related articles

Photo

News • Philips joins European Federation for Cancer Images (EUCAIM)

Advancing precision medicine for Europe’s cancer patients

Philips is an active participant in the new European Federation for Cancer Images consortium (EUCAIM) – a project launched in the run-up to World Cancer Day 2023.

Photo

News • Imaging study shows

Breast MRI effective at detecting cancer in dense breasts

Compared to other common supplemental screening methods, breast MRI was superior at detecting breast cancer in women with dense breasts, according to a new study.

Photo

Medical display

JVC – CL-S1200

The CL-S1200 is a 30.9-inch color monitor with 12 megapixels for reporting medical images of various modalities such as CT, CR/DR, MR, ultrasound or mammography.

Related products

32 Inch Height-Adjustable MRI LED Screen

Accessories / Complementary Systems

allMRI · 32 Inch Height-Adjustable MRI LED Screen

allMRI GmbH
Accutron MR

Injectors

Medtron AG · Accutron MR

MEDTRON AG
Accutron MR3

Injectors

Medtron AG · Accutron MR3

MEDTRON AG
Advanced intelligent Clear-IQ Engine for MR

Artificial Intelligence

Canon · Advanced intelligent Clear-IQ Engine for MR

Canon Medical Systems Europe B.V.
Airis Vento Plus

Open

Fujifilm · Airis Vento Plus

FUJIFILM Europe GmbH
Aperto Lucent Plus

Open

Fujifilm · Aperto Lucent Plus

FUJIFILM Europe GmbH
Subscribe to Newsletter